18 May 2021
Cardiovascular Innovation Pipeline: Transcatheter Mitral Replacement Devices
Session comprising selected EuroPCR 2021 Cardiovascular Innovation Pipeline submissions
Summary
Mitral regurgitation is a leading cause of valvular heart disease in Western countries. Transcatheter mitral valve replacement (TMVR) has emerged as a potential therapeutic option for patients with severe mitral disease who are at high risk for conventional surgery. Watch these presentations to find out about an innovative new device for the treatment of mitral disease.
